Establishment Labs Holdings Inc (NAS:ESTA)
$ 85.81 (0%) Market Cap: 2.53 Bil Enterprise Value: 2.72 Bil PE Ratio: 0 PB Ratio: 171.62 GF Score: 75/100

Establishment Labs Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 05:45PM GMT
Release Date Price: $66.19 (+1.63%)
Allen Gong
JPMorgan Chase & Co - Analyst

Okay. Thanks, everyone, for being here. I'm really excited to be introducing some of the management team from Establishment Labs. We're going to be starting off with a presentation from CEO, Peter Caldini, and then Raj Denhoy, CFO, will be joining us for some Q&A afterwards.

Fillipo Caldini
Establishment Labs Holdings Inc - Chief Executive Officer, Director

Great. Thank you. Thank you very much. It's a great pleasure to be here, really an opportunity to share some exciting news and exciting update on Establishment Labs. We just completed a very successful 2025. And I think most importantly, we're very well positioned for strong significant growth in 2026 and beyond.

So for those of you that are not as familiar with the Establishment Labs story, we are a medical technology company focused on breast aesthetics and reconstruction. We really drive innovation to improve women's health and well-being.

So we've been around for 20 years. We sold over 4.5 million devices worldwide, and we're in 90

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot